查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球活細胞成像市場-2022-2029
市場調查報告書
商品編碼
1129280

全球活細胞成像市場-2022-2029

Global Live Cell Imaging Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

利用活細胞成像新技術研究細胞生物學有望推動市場增長。

香港科技大學 (HKUST) 的研究人員開發出新一代顯微鏡，可捕捉 3D 活細胞電影並產生顯著更高質量的圖像，顯著提高細胞生物學研究的精度和範圍。改進為另一方面，由香港科技大學杜勝旺教授和 Michael Loy 教授領導的團隊開發的 LiTone Line Bessel Sheet (LBS) 顯微鏡的光毒性比目前的共聚焦顯微鏡低 1000 倍，使細胞生長時間更長.時間可以觀察。此外，它是一項基於廣泛科學和工程的強大技術，但為用戶簡化了，因此即使是不太專業的生物學家也可以使用它。隨著時間的推移，科學家們或許能夠解開某些疾病如何在細胞水平上形成和發展的奧秘。因此，從上述陳述來看，預計將在預測期內推動市場。

限制

先進的活細胞成像技術和設備價格昂貴，缺乏熟練的專業人員，政府對設備和軟件類型的嚴格批准是在預測期內阻礙市場的一些因素。考慮。

行業分析

活細胞成像市場基於供應鏈分析、報銷方案和定價分析等各種行業因素對市場進行了深入分析。

COVID-19 影響分析

COVID-19 大流行對醫療保健系統和市場產生了適度影響。 COVID-19 研究人員正在使用遠程活細胞成像技術來監測和研究病毒感染的細胞，而無需進入實驗室。這可以節省時間並降低與 COVID-19 研究相關的風險。目前用於檢查 SARS-CoV-2 細胞進入的基於細胞的檢測使用真正的病毒或帶有尖峰的假型病毒，這很耗時，需要生物安全設施和多步實驗技術。這極大地阻礙了相關研究，尤其是高通量篩選實驗。一些研究人員已經使用活細胞成像進行可視化，我們開發了一種可量化的熒光 SARS-CoV-2 進入探針。世界各地的研究人員正在研究產生 COVID-19 的病毒 SARS-CoV-2。在病毒研究期間，研究人員可以利用活細胞成像方法（例如先進的顯微鏡設備）來分析細胞活動。基於病毒學的研究需要處理大量數據才能進行疫苗接種。

另一方面，大流行會破壞供應鍊和流程。許多公司轉移到其他地區以確保產品可用性並保護其供應鏈。因此，從上面這句話來看，市場受到了影響，預計隨著經濟活動的恢復，市場將迅速獲得牽引力。

全球活細胞成像市場報告提供大約 45 多個市場數據表、40 多個圖表和 180 頁內容。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 為細胞生物學研究捕獲活細胞圖像的新技術的開發預計將推動市場增長。
    • 限制因素
      • 缺乏熟練的專業人員以及政府對設備類型的嚴格批准預計會阻礙市場增長。
    • 市場機會
    • 影響分析

第五章行業分析

  • 供應鏈分析
  • 定價分析
  • 未滿足的需求分析
  • 管道分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 設備
    • 獨立系統
    • 顯微鏡
    • 細胞分析儀
    • 圖像捕捉設備
    • 其他
  • 消耗品
    • 試劑和試劑盒
    • 其他
  • 軟件
  • 其他

第 8 章技術

  • 光漂白後的熒光恢復方法
  • 熒光共振能量轉移法
  • 高內容分析
  • 熒光原位雜交
  • 其他

第 9 章。按應用程序

  • 藥物發現
  • 細胞生物學
  • 發育生物學
  • 幹細胞
  • 其他

第 10 章，最終用戶

  • 製藥公司、生物技術公司
  • 診斷實驗室
  • 醫院
  • 學術和研究機構
  • 其他

第 11 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 12 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準
  • 值得關注的重點公司列表

第 13 章公司簡介

  • 珀金埃爾默公司
    • 公司簡介
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Live Cell Instruments
  • Zeiss Group
  • Axion BioSystems, Inc
  • Becton, Dickinson and Company
  • CYTENA
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies
  • Cytiva

第 14 章全球活細胞成像市場-DataM

簡介目錄
Product Code: DMBT5828

Market Overview

Live Cell Imaging Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 8.8 % during the forecast period (2022-2029).

Live-cell imaging has revolutionized how scientists study cells, proteins, various processes and complicated molecular interactions. Using live-cell imaging techniques, researchers may view cell shapes and functions in real-time and over time. Instead of simply presenting an image of a cell's current state, live-cell imaging enables the visualization and characterization of dynamic cellular events and processes in real-time. Exploring dynamic processes, viewing the localization and mobility of particular molecules, and analyzing structural aspects of a cell are some of the most important uses of live cell imaging. Furthermore, live-cell imaging techniques enable scientists to monitor the physiological integrity of cells and other cellular and molecular processes such as exocytosis, signal transduction, enzyme activity, and protein trafficking.

Market Dynamics

The development of new technology to capture live cell images to study cell biology is expected to drive market growth.

Researchers at The Hong Kong University of Science and Technology (HKUST) have developed a new generation of microscopes that captures 3D live-cell movies and produces considerably higher quality images, greatly improving the accuracy and scope of cell biology research. The LiTone Line Bessel Sheet (LBS) microscope developed by a team led by Prof Du Shengwang and Prof Michael Loy from HKUST, on the other hand, is 1,000 times less photo-toxic than the present confocal model, allowing the cell to be observed for much longer. Moreover, it is a powerful technology based on extensive science and engineering, but we simplify it for users so that biologists with little expertise may use it. That could eventually help scientists unlock the mystery of how certain diseases were formed and developed at a cellular level. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

Advanced live-cell imaging technology and equipment are expensive, lack of skilled professionals and stringent government approvals for types of equipment and software are some factors the market is expected to get hampered in the forecast period.

Industry Analysis

The live cell imaging market provides in-depth analysis of the market based on various industry factors such as supply chain analysis, reimbursement scenario, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. COVID-19 researchers employ remote live-cell imaging to monitor and investigate virus-infected cells without entering the lab. This saves time and reduces the risks involved with the COVID-19 study. Current cell-based assays for examining SARS-CoV-2 cell entrance involve either an actual virus or spike-bearing pseudotyping viruses, which is time-consuming and necessitates biosafety facilities and multistep experimental techniques. This has significantly hampered relevant investigations, particularly high-throughput screening experiments. Several researchers have developed a fluorescent SARS-CoV-2 entry probe that can be visualized and quantified using live-cell imaging to implement an ideal system for high-throughput screening SARS-CoV-2 entry inhibitors in virus-free environments supporting antibody and vaccine development. SARS-CoV-2, the virus that produces COVID-19, is being studied by several worldwide researchers. Researchers can utilize live-cell imaging methods, such as advanced microscopy equipment, during the viral study to analyze cellular activities. Virology-based research necessitates the processing of vast amounts of data to generate vaccinations.

In contrast, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Segment Analysis

Equipment segment is expected to hold the largest market share in live cell imaging market

The equipment segment is expected to dominate in 2021. The segment is further sub-segmented into standalone systems, microscopes, cell analyzers, and image capturing devices. In this, Equipment or devices that can function independently of other hardware and are not integrated into another device are called standalone systems. The extensive use of these systems in live-cell imaging and the rising emphasis on research and technological development are the primary reasons driving the segment's growth. Moreover, according to a February 2022 update, TGen and Deepcell partnered to classify and isolate sick cells using artificial intelligence-based technology. Deepcell's AI-powered technology transforms cell morphology into a quantitative and high throughput marker for use in research and a novel independent way to supplement existing molecular procedures. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global live cell imaging market

In 2021, North America accounted for the highest revenue share. The rising geriatric population, significant commitment and funding available for live-cell imaging research, high adoption of innovative treatments, the presence of large pharmaceutical corporations and prominent research institutes, as well as their active involvement in the development and commercialization of novel, enhanced live-cell imaging systems in the region are some of the factors the market is expected to boost in the forecast period. For instance, PHC Corporation of North America announced cooperation with SCREEN Holdings Co., Ltd. on September 21, 2021, to market and distributed the SCREEN Cell3iMager family of live-cell imaging equipment in North America. Moreover, biopharmaceutical companies invested more than a trillion dollars in research and development over the last decade, including a record-breaking year in 2020, when PhRMA member companies invested approximately USD 91 billion in research and development. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the live cell imaging market are PerkinElmer Inc, Live Cell Instruments, Zeiss Group, Axion BioSystems, Inc, Becton, Dickinson and Company, CYTENA, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Agilent Technologies , Cytiva.

PerkinElmer Inc.:

Overview:

PerkinElmer is a leading, global provider of end-to-end solutions that help scientists, researchers, and clinicians better diagnose disease, discover new and more personalized drugs, monitor the safety and quality of our food, and drive environmental and applied analysis excellence. The company has a dedicated team of more than 16,000 and collaborates closely with commercial, government, academic, and healthcare customers to deliver reagents, assays, instruments, automation, informatics, and strategic services that accelerate workflows, deliver actionable insights, and support improved decision making. The company serves customers in 190 countries and is a component of the S&P 500 index.

Product Portfolio:

MuviCyte Live-Cell Imaging Kit: The MuviCyte live-cell imaging system works inside your cell-culture incubator, allowing you to keep your cells in ideal conditions while performing various experiments in different culture containers. The MuviCyte live-cell imaging package includes a live-cell imaging apparatus as well as 4x, 10x, and 20x objective lenses, a PC, and a monitor.

The global live cell imaging market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The development of new technology to capture live cell images to study cell biology is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of skilled professionals and stringent government approvals for types of equipment are expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Unmet Needs
  • 5.4. Pipeline Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Equipment
    • 7.2.1. Standalone Systems
    • 7.2.2. Microscopes
    • 7.2.3. Cell Analyzers
    • 7.2.4. Image Capturing Devices
    • 7.2.5. Others
    • 7.2.6. Introduction
    • 7.2.7. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Consumables
    • 7.3.1. Reagents and Kits
    • 7.3.2. Others
  • 7.4. Software
  • 7.5. Others

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology Segment
  • 8.2. Fluorescence Recovery After Photobleaching*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Fluorescence Resonance Energy Transfer
  • 8.4. High-content Analysis
  • 8.5. Fluorescence In Situ Hybridization
  • 8.6. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application Segment
  • 9.2. Drug Discovery*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Cell Biology
  • 9.4. Developmental Biology
  • 9.5. Stem Cells
  • 9.6. Others

10. By End user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.1.2. Market Attractiveness Index, By End user Segment
  • 10.2. Pharmaceutical and Biotechnology Companies*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Diagnostic Laboratories
  • 10.4. Hospitals
  • 10.5. Academic and Research Institutes
  • 10.6. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. PerkinElmer Inc.*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Live Cell Instruments
  • 13.3. Zeiss Group
  • 13.4. Axion BioSystems, Inc
  • 13.5. Becton, Dickinson and Company
  • 13.6. CYTENA
  • 13.7. Thermo Fisher Scientific
  • 13.8. Bio-Rad Laboratories, Inc.
  • 13.9. Agilent Technologies
  • 13.10. Cytiva

LIST NOT EXHAUSTIVE

14. Global Live Cell Imaging Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us